Top Biotech Companies in Los Angeles, CA (117)
A clinical-stage biopharmaceutical company advancing the development of new biologics for cancer treatment. TORL-Bio was founded in 2018 and is focused on the development of novel antibody-based therapeutics for cancer patients. TORL has currently 3 therapeutics in Ph1 clinical trials in indications such as NSCLC, gastric, pancreatic and ovarian cancers.
For 85 years, PerkinElmer has pushed the boundaries of science from food to health to the environment. We’ve always pursued science with a clear purpose – to help our customers achieve theirs. Our expert team brings technology and intangibles, like creativity, empathy, diligence, and a spirit of collaboration, in equal measure, to fulfill our customers’ desire to work better, innovate...
PerkinElmer's Top Stability & Growth Strengths
Strong Market Position & Advantage: Colleagues are often seen as operating from a top-tier competitive position in applied, food, and environmental analytical markets, including a significant presence in food testing and leadership in multivendor lab services via OneSource. The large global installed base and asset footprint are portrayed as reinforcing defensibility and ongoing demand for services and support.
Innovation-Driven Growth: Colleagues are often seen as sustaining relevance through ongoing product launches and upgrades such as digital PCR systems, updated LIMS software, and new analytical platforms aimed at emerging needs like PFAS detection and battery applications. The continued cadence of new instruments and workflow solutions is positioned as a key growth lever alongside services and consumables.
Investor Backing & Capital Strength: Colleagues are often seen as supported by private-equity ownership under New Mountain Capital and described with a substantial valuation, suggesting access to capital and an explicit mandate to scale. Recent acquisitions (e.g., Covaris and Project Farma) are framed as capability-building moves consistent with a funded expansion strategy.
Thrivelab is a telehealth-based provider of evidence-based hormone and testosterone balancing programs as well as natural bioidentical products to alleviate age-related symptoms and restore youthful vitality.
Tilda Research, based in San Francisco, is an innovator in clinical research execution. We focus on data integration, site-wide automation and real-time operational metrics to enable faster bench-to-market solutions for our research partners. We operate a growing network of clinical research sites in the US, and our team has worked on over 250 pan-indication Phase I thru IV studies.
Phenomenex is a manufacturer and distributor of high-value consumables for the separation sciences.
Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We are committed to sustainability by responsibly managing the materials we create for their entire lifecycle and are growing our portfolio of sustainable...
Gather Labs is a High Complexity CLIA Lab and wellness boutique focused on sparking joy in the diagnostic experience. We offer same day resulting for all diagnostic tests.
Founded in 1996, PSC Biotech Corporation was created with the vision of providing life science companies unmatched support. To date, PSC Biotech Corporation now serves 1000 clients in more than 35 countries worldwide through professional services consulting, cloud-based software solutions, pharmaceuticals contract manufacturing, life science investment consulting, and metrology services. PSC Biotech Corporation has six unique divisions within the parent company...
Wyatt Technology is the leading provider of advanced tools for the characterization of macromolecules and nanoparticles in solution, measuring absolute molar mass, size, charge and interactions. Our technology includes the finest instruments and software available for: chromatographic and composition-gradient multi-angle static light scattering, high-throughput dynamic light scattering, field flow fractionation, differential refractometry, electrophoretic mobility and differential viscometry.
Right from the beginning, which is now more than fifty years ago, Bruker has been driven by a single idea: to provide the best technological solution for each analytical task. Today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. Bruker systems cover a broad spectrum of applications in...
Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Santa Monica, CA and Amsterdam, the Netherlands, Neogene is aiming to change the paradigm of treatment for solid cancers. Neogene is a member of the AstraZeneca Group
Chemistry is the key to drug discovery, but chemical data is stuck in the twentieth century. We’re generating precise chemical datasets purpose-built to propel drug discovery into the information age — and we’re doing it on a larger scale and faster than has ever before been possible. Terray Therapeutics is a biotechnology company led by pioneers and long-time leaders in artificial...
Terray Therapeutics's Top Stability & Growth Strengths
Investor Backing & Capital Strength: The company has secured over $200 million in total funding, including an oversubscribed $120 million Series B in October 2024 led by Bedford Ridge Capital and NVentures, indicating strong investor confidence. The raise is directed to advance internal immunology programs toward clinical trials and to further enhance and scale its integrated AI platform.
Strategic Partnerships: Multi-target collaborations with Bristol Myers Squibb, Calico, Gilead, and Odyssey, along with a discovery milestone announced with BMS in December 2025, provide external validation and milestone-driven momentum. These agreements span multiple targets and disease areas, signaling durable partner demand for the platform.
Innovation-Driven Growth: Terray has advanced an experiment-integrated AI stack (tNova/EMMI, COATI, TerraBind) and reports billions of measured target–ligand interactions powering rapid design cycles. Platform updates include first-time applications like latent diffusion for small molecule design and reported gains in potency prediction speed and accuracy.
Varda Space Industries was founded in 2020 with the goal of manufacturing products in space to benefit life on Earth. Co-founders Will Bruey and Delian Asparouhov imagined a world where space could be leveraged not only for storytelling and awe, but for its economic benefits. Varda was created as a platform for in-space manufacturing, with a range of real-life, on-Earth...
The way we see it, the impossible is not impossible. It’s simply what hasn’t been achieved yet. For more than 30 years, we’ve pursued it, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases. Creating Possible drives everything we do. It’s evident in our...
Gilead Sciences's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is a leader in HIV and maintains a top position in CAR‑T (Yescarta) while building a credible oncology footprint. Leadership is reinforced by durable HIV demand across treatment and prevention, with new lenacapavir offerings extending the franchise.
Resilient & Sustainable Growth: Recent results show modest headline growth with stronger momentum in the core base business and management guiding to continued base‑business expansion in 2026. COVID normalization and CAR‑T competition moderate the pace, but HIV and liver disease strength provide steady underpinning.
Future-Ready Strategy: The pipeline advances lenacapavir‑based regimens and multiple oncology programs, with near‑term launches and read‑throughs that can support growth beyond 2026. Prevention initiatives and oncology scaling are positioned as key execution pillars for medium‑term expansion.
Scripps Research is a leader in the discovery and application of biomedical breakthroughs that improve human health. As the world's largest independent non-profit biomedical research facility, we expand the frontiers of science and education and create hope for millions. Scripps Research is ranked #1 for innovation by the Nature Index.
We believe in harnessing science for human good. And so we work day and night, around the world, to deliver answers for all your health questions—whether you’re a provider, drug developer, hospital, medical researcher or patient. That means everything from advancing diagnostic testing to helping launch new drugs, to offering new perspectives through data - all drawing from a deep...
Trusted by the world's leading organizations, Point B is a consulting firm that works at the intersection of expertise, industry insight, and transformative technology. This collaborative approach enables you to solve your most important challenges, by bringing together the right mix of talent and technology to deliver greater value and impact. With over 850 associates in the US and 3000+...
Ambrx Inc., is a clinical-stage biopharmaceutical company focused on developing Precision Biologics using an expanded genetic code. Ambrx technology uses an expanded genetic code to incorporate synthetic amino acids into protein, all completed within a living cell. These synthetic amino acids enable the creation of Precision Biologics, an exciting new class of therapeutics with broad application and potential. This includes...
Kernel creates the interfaces and insights necessary to unlock the greatest scientific unknown: the inner workings of the human brain and mind. Kernel is a full-stack neurotech company founded in 2016 with the mandate to do something that will change the world. Kernel is leveraging the best non-invasive brain scanning techniques to create next-generation technologies that dramatically expand the accuracy,...
Xcenda’s strategic consulting and field reimbursement services help pharmaceutical and biotech manufacturers thrive in global, value-driven healthcare markets. Our areas of expertise include health economics and outcomes research, reimbursement and global market access strategy, market research, and health policy analysis, as well as the development of value demonstration tools, scientific publications, training programs and outsourced field reimbursement teams. We apply...
